Cited by 323Dialysis and Renal Disease ManagementDiabetes Management and ResearchAdvanced Glycation End Products research

Comparison of glycated albumin and hemoglobin A1c levels in diabetic subjects on hemodialysis

Open access
Peacock, T.P., Shihabi, Z.K., Bleyer, A.J., Dolbare, E.L., Byers, J.R., Knovich, M.A., Calles-Escandon, J., Russell, G.B. +1 more·2008·Kidney International

Abstract

Glycated albumin is thought to more accurately reflect glycemic control in diabetic hemodialysis patients than hemoglobin A(1c) because of shortened red cell survival. To test this, glycated hemoglobin and albumin levels were measured in blood samples collected from 307 diabetic subjects of whom 258 were on hemodialysis and 49 were without overt renal disease. In diabetic subjects with renal disease, relative to those without, the mean serum glucose and glycated albumin concentrations were significantly higher while hemoglobin A(1c) tended to be lower. The glycated albumin to hemoglobin A(1c) ratio was significantly increased in dialysis patients compared with the controls. Hemoglobin A(1c) was positively associated with hemoglobin and negatively associated with the erythropoietin dose in hemodialysis patients, whereas these factors and serum albumin did not significantly impact glycated albumin levels. Using best-fit multivariate models, dialysis status significantly impacted hemoglobin A(1c) levels without a significant effect on glycated albumin. Our results show that in diabetic hemodialysis patients, hemoglobin A(1c) levels significantly underestimate glycemic control while those of glycated albumin more accurately reflect this control.

Integrity signals

Registry

Crossref · 10.1038/ki.2008.25

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Accuracy and precision of HbA1c measurement declines with advanced CKD (G4-G5), particularly among patients treated by dialysis, in whom HbA1c measurements have low reliability.

    “Practice Point 2.1.2: Accuracy and precision of HbA1c measurement declines with advanced CKD (G4 -G5), particularly among patients treated by dialysis, in whom HbA1c measurements have low reliability.”
  • Correlations of directly measured blood glucose levels with HbA1c, glycated albumin, and fructosamine were progressively weaker with advanced CKD stages (G4-G5), especially kidney failure treated by dialysis.

    “Correlations of directly measured blood glucose levels with 3 glycemic biomarkers -HbA1c, glycated albumin, and fructosamine -were progressively weaker with advanced CKD stages (G4 -G5), especially kidney failure treated by dialysis. 196,197,205,210,227”

Cites

Flagged first, then by citations

1 of the 22 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Peacock, T. P., Shihabi, Z. K., Bleyer, A. J., Dolbare, E. L., Byers, J. R., Knovich, M. A., Calles-Escandon, J., Russell, G. B., & Freedman, B. I.
Affiliations
Wake Forest University Health Sciences (US)
Corresponding author
Freedman, B.I.
Venue
Kidney International
Publisher
Elsevier BV
Published
2008-05
Volume
73
Issue
9
Pages
1062-1068
ISSN
0085-2538 (ISSN-L)
OpenAlex
W2040722615
Cited by
323
References
22
Citations by year
2026: 5 · 2025: 9 · 2024: 6 · 2023: 6 · 2022: 18 · 2021: 11 · 2020: 15 · 2019: 14 · 2018: 19 · 2017: 17 · 2016: 20 · 2015: 26 · 2014: 27 · 2013: 33 · 2012: 24
FWCI
19.04
Type
journal article
Language
en
Open access
Locations
  • Kidney International (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Keywords
glycated albumin, HbA1c, glycemic control, diabetes mellitus, hemodialysis, erythropoietin, hemoglobin, serum albumin, kidney disease
MeSH terms
Glycated Serum Albumin, Diabetes Mellitus, Female, Renal Dialysis, Glycated Hemoglobin, Humans, Male, Middle Aged, Serum Albumin, Glycation End Products, Advanced

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review